Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer. Dean Marleah et al. Health communication 2016 Dec 1-9

Public Health Genomics Knowledge Base (v1.2)

Last Posted: Dec-23-2016 2PM

Last Posted: Dec 22, 2016

---

• Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
  Antonucci Ivana et al. Journal of human genetics 2016 Dec
• Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
  Dean Marleah et al. Health communication 2016 Dec 1-9
• BRCA mutation genetic testing implications in the United States.
  Bayraktar Soley et al. Breast (Edinburgh, Scotland) 2016 Dec 31224-232
• BRCA Status Does Not Predict Survival for Young Patients With Breast Cancer
  J Daley, Cancer Therapy Advisor, December 9, 2016
• Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
  George Angela et al. Nature reviews. Clinical oncology 2016 Dec
• Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
  Lieberman Sari et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dec
• Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.
  Lieberman Sari et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dec
• Population-Based Study of Attitudes toward BRCA Genetic Testing among Orthodox Jewish Women.
  Tang Eve Y et al. The breast journal 2016 Nov
• Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.
  D'Andrea Elvira et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dec 18(12) 1171-1180
• DATA SHARING AND REPRODUCIBLE CLINICAL GENETIC TESTING: SUCCESSES AND CHALLENGES.
  Yang Shan et al. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2016 22166-176
• Orthodox Jewish Thought Leaders' Insights Regarding BRCA Mutations: A Descriptive Study.
  Bressler Toby et al. Journal of oncology practice 2016 Nov JOP2016015503
• Revisiting the morbid genome of Mendelian disorders.
  Abouelhoda Mohamed et al. Genome biology 2016 Nov 17(1) 235
• The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.
  Toss Angela et al. Oncotarget 2016 Nov
• Tracking the dissemination of a culturally targeted brochure to promote awareness of hereditary breast and ovarian cancer among Black women.
  Scherr Courtney Lynam et al. Patient education and counseling 2016 Oct
• Detection of false positive mutations in BRCA gene by next generation sequencing.
  Suryavanshi Moushumi et al. Familial cancer 2016 Nov
• Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.
  Vergote Ignace et al. European journal of cancer (Oxford, England : 1990) 2016 Nov 69127-134

more

---

Most Recent Scientific Publications from Weekly Horizon Scans

From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

• Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
  Dean Marleah et al. Health communication 2016 Dec 1-9
• Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
  Antonucci Ivana et al. Journal of human genetics 2016 Dec
• Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
  George Angela et al. Nature reviews. Clinical oncology 2016 Dec
• BRCA mutation genetic testing implications in the United States.
  Bayraktar Soley et al. Breast (Edinburgh, Scotland) 2016 Dec 31224-232
• Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
  Lieberman Sari et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dec

more